
Collaborating with colleagues at Princess Margaret Cancer Centre in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) in Phoenix have discovered why multiple myeloma frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years.
“Some myeloma cells are too immature to be caught by the drugs and thus hide underground only to reemerge later,” says Keith Stewart, M.B., Ch.B., Dean for Research at Mayo Clinic in Arizona and contributor to the study. “This study has wide implications in the search for a cure of this common blood cancer as this ‘progenitor cell’ will have to be targeted.”
The study is published in the Sept. 9 issue of Cancer Cell.
Click here to read the full news release.
World AIDS Day, observed on Dec. 1, raises awareness about HIV/AIDS and pays tribute to those affected by the disease. Globally, about 39 million people are living ...
Lung cancer is the largest cancer killer of adult men and women worldwide. One of the reasons is that by the time symptoms develop, the ...
During breaks from his doctoral research in London, Richard Vile, Ph.D., would visit a pediatric brain tumor clinic next to his lab for inspiration. Seeing children ...